Home
|
Learning Center
|
中文版
Publications
站内成果搜索:
搜索
Ceftriaxone-Resistant Salmonella enterica Serotype Typhimurium Sequence Type 313 from Kenyan Patients Is Associated with the bla(CTX-M-15) Gene on a Novel IncHI2 Plasmid
Ceftolozane/Tazobactam: A New Cephalosporin and beta-Lactamase Inhibitor Combination
Ceftibuten-containing agar plate for detecting group B streptococci with reduced penicillin susceptibility (PRGBS)
Ceftolozane/Tazobactam Plus Metronidazole for Complicated Intra-abdominal Infections in an Era of Multidrug Resistance: Results From a Randomized, Double-Blind, Phase 3 Trial (ASPECT-cIAI)
Ceftolozane-tazobactam versus levofloxacin in urinary tract infection
Ceftobiprole and ampicillin increase daptomycin susceptibility of daptomycin-susceptible and - resistant VRE
Ceftriaxone attenuates acute cocaine-evoked dopaminergic neurotransmission in the nucleus accumbens of the rat
Ceftolozane-tazobactam: A new-generation cephalosporin
Ceftriaxone reverses ketamine-induced lasting EEG and astrocyte alterations in juvenile mice
Ceftolozane/tazobactam for the treatment of complicated intra-abdominal infections
Ceftaroline CSF concentrations in a patient with ventriculoperitoneal shunt-related meningitis
Ceftriaxone attenuates ethanol drinking and restores extracellular glutamate concentration through normalization of GLT-1 in nucleus accumbens of male alcohol-preferring rats
Ceftaroline fosamil salvage therapy: an option for reduced-vancomycin-susceptible MRSA bacteraemia
Ceftriaxone-induced Hemolytic Anemia: Case Report and Review of Literature
Ceftriaxone attenuates acquisition and facilitates extinction of cocaine-induced suppression of saccharin intake in C57BL/6J mice
Ceftriaxone and cefazolin attenuate the cue-primed reinstatement of alcohol-seeking
Ceftriaxone-associated cholelithiasis: 30 min drip infusion versus bolus injection
Ceftiofur derivates in serum and endometrial tissue after intramuscular administration in healthy mares
Ceftobiprole Is Superior to Vancomycin, Daptomycin, and Linezolid for Treatment of Experimental Endocarditis in Rabbits Caused by Methicillin-Resistant Staphylococcus aureus
Ceftriaxone-induced up-regulation of cortical and striatal GLT1 in the R6/2 model of Huntington's disease
Ceftiofur Resistance in Salmonella enterica Serovar Heidelberg from Chicken Meat and Humans, Canada
Ceftriaxone-related agranulocytosis during outpatient parenteral antibiotic therapy
Ceftriaxone Restores Glutamate Homeostasis and Prevents Relapse to Cocaine Seeking
Ceftaroline activity against pathogens associated with complicated skin and skin structure infections: results from an international surveillance study
Ceftaroline: A New Cephalosporin with Activity Against Resistant Gram-Positive Pathogens
Ceftriaxone has a therapeutic role in Alexander disease
Ceftaroline for complicated skin and skin-structure infections
Ceftazidime/avibactam: a novel cephalosporin/nonbeta-lactam beta-lactamase inhibitor for the treatment of complicated urinary tract infections and complicated intra-abdominal infections
Ceftaroline as Salvage Monotherapy for Persistent MRSA Bacteremia
Ceftriaxone prevents the neurodegeneration and decreased neurogenesis seen in a Parkinson%26apos;s disease rat model: An immunohistochemical and MRI study
Ceftiofur pharmacokinetics in Nile tilapia Oreochromis niloticus after intracardiac and intramuscular administrations
Ceftriaxone pretreatment reduces the propensity of postpartum depression following stroke during pregnancy in rats
Ceftazidime/Avibactam and Ceftolozane/Tazobactam: Second-generation beta-Lactam/beta-Lactamase Inhibitor Combinations
Ceftazidime-avibactam (CTZ-AVI) as a treatment for hospitalized adult patients with complicated intra-abdominal infections
Ceftazidime-avibactam or best available therapy in patients with ceftazidime-resistant Enterobacteriaceae and Pseudomonas aeruginosa complicated urinary tract infections or complicated intra-abdominal infections (REPRISE): a randomised, pathogen-directed, phase 3 study
Ceftaroline fosamil as first-line versus second-line treatment for acute bacterial skin and skin structure infections (ABSSSI) or community-acquired bacterial pneumonia (CABP)
Ceftriaxone-associated renal toxicity in adults: a case report and recommendations for the management of such cases
Ceftriaxone improves spatial learning and memory in chronic cerebral hypoperfused rats
Ceftobiprole: a new beta-lactam antibiotic
Ceftaroline Fosamil: A Cephalosporin With Activity Against Methicillin-Resistant Staphylococcus Aureus
Ceftaroline A Novel Broad-Spectrum Cephalosporin with Activity against Meticillin-Resistant Staphylococcus aureus
Ceftobiprole: a novel cephalosporin with activity against Gram-positive and Gram-negative pathogens, including methicillin-resistant Staphylococcus aureus (MRSA)
Ceftaroline fosamil for the treatment of acute bacterial skin and skin structure infections
Ceftaroline fosamil and treatment of acute bacterial skin and skin structure infections: CAPTURE study experience
Ceftaroline fosamil: a new cephalosporin active against resistant Gram-positive organisms including MRSA
Ceftriaxone treatment failure of pharyngeal gonorrhoea verified by international recommendations, Sweden, July 2010
Ceftobiprole: breaking therapeutic dogmas of the beta-lactam class
Ceftaroline Activity Tested Against Bacterial Isolates From Pediatric Patients Results from the Assessing Worldwide Antimicrobial Resistance and Evaluation Program for the United States (2011-2012)
Ceftriaxone Preconditioning Confers Neuroprotection in Neonatal Rats Through Glutamate Transporter 1 Upregulation
Ceftaroline: A Novel Cephalosporin with Activity against Methicillin-resistant Staphylococcus aureus
Ceftaroline fosamil: a new broad-spectrum cephalosporin
Ceftaroline Fosamil in the Treatment of Community-Acquired Bacterial Pneumonia and Acute Bacterial Skin and Skin Structure Infections
Ceftaroline Fosamil: A Novel Broad-Spectrum Cephalosporin with Activity Against Methicillin-Resistant Staphylococcus aureus
Ceftaroline Fosamil: A Review of its Use in the Treatment of Complicated Skin and Soft Tissue Infections and Community-Acquired Pneumonia
Ceftaroline activity against organisms isolated from respiratory tract infections in USA hospitals: results from the AWARE program, 2009-2011
Ceftiofur-loaded PHBV microparticles: A potential formulation for a long-acting antibiotic to treat animal infections
Ceftazidime for respiratory infections
Ceftriaxone, a Beta-Lactam Antibiotic, Reduces Ethanol Consumption in Alcohol-Preferring Rats
Ceftobiprole Efficacy In Vitro against Panton-Valentine Leukocidin Production and In Vivo against Community-Associated Methicillin-Resistant Staphylococcus aureus Osteomyelitis in Rabbits
Ceftriaxone Resistance and Genes Encoding Extended-Spectrum beta-Lactamase among Non-Typhoidal Salmonella Species from a Tertiary Care Hospital in Kuala Lumpur, Malaysia
Ceftaroline in the treatment of concomitant methicillin-resistant and daptomycin-non-susceptible Staphylococcus aureus infective endocarditis and osteomyelitis: case report
Ceftolozane/tazobactam for the treatment of complicated urinary tract and intra-abdominal infections
Ceftriaxone Normalizes Nucleus Accumbens Synaptic Transmission, Glutamate Transport, and Export following Cocaine Self-Administration and Extinction Training
Ceftriaxone mediated rescue of nigral oxidative damage and motor deficits in MPTP model of Parkinson's disease in rats
Ceftaroline: a cephalosporin with expanded Gram-positive activity
Ceftaroline versus Ceftriaxone in a Highly Penicillin-Resistant Pneumococcal Pneumonia Rabbit Model Using Simulated Human Dosing
Ceftriaxone protects against the neurotoxicity of human immunodeficiency virus proteins
Ceftolozane/tazobactam (CXA 201) for the treatment of intra-abdominal infections
Ceftazidime-resistant Enterobacteriaceae isolates from three Polish hospitals: Identification of three novel TEM- and SHV-5-type extended-spectrum beta-lactamases
Ceftriaxone-resistant Salmonella enterica serovar hadar: Evidence for interspecies transfer of bla(cmy-2) in a Taiwanese university hospital
Ceftaroline fosamil for treatment of community-acquired pneumonia: findings from FOCUS 1 and 2 and potential role in therapy
Ceftaroline: a comprehensive update
Ceftazidime/avibactam activity tested against Gram-negative bacteria isolated from bloodstream, pneumonia, intra-abdominal and urinary tract infections in US medical centres (2012)
Ceftazidime-hydrolysing beta-lactamase OXA-145 with impaired hydrolysis of penicillins in Pseudomonas aeruginosa
Ceftaroline fosamil for community-acquired bacterial pneumonia and acute bacterial skin and skin structure infection
Ceftriaxone and Infection in First Episode Adolescent Psychosis
Ceftriaxone crystallization and its potential role in kidney stone formation
Ceftiofur Use in Finishing Swine Barns and the Recovery of Fecal Escherichia coli or Salmonella spp. Resistant to Ceftriaxone
Ceftaroline Potency Among 9 US Census Regions: Report From the 2010 AWARE Program
Ceftolozane/tazobactam activity tested against Gram-negative bacterial isolates from hospitalised patients with pneumonia in US and European medical centres (2012)
Ceftriaxone prevents the induction of cocaine sensitization and produces enduring attenuation of cue- and cocaine-primed reinstatement of cocaine-seeking
Ceftriaxone, a GLT-1 transporter activator, disrupts hippocampal learning in rats
Ceftazidime-Resistant Salmonella enterica, Morocco
Ceftaroline fosamil for treating skin and skin structure infections or community-acquired pneumonia in patients with renal insufficiency
Ceftolozane-tazobactam compared with levofloxacin in the treatment of complicated urinary-tract infections, including pyelonephritis: a randomised, double-blind, phase 3 trial (ASPECT-cUTI)